triphenyltetrazolium has been researched along with Cerebral Arterial Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chmielewski, PA; Johnson, MP; Koehl, JR; Linnik, MD; Markgraf, CG; McCarty, DR; Medhi, S; Velayo, NL | 1 |
Alkayed, NJ; Harukuni, I; Hurn, PD; Kimes, AS; London, ED; Traystman, RJ | 1 |
Fisher, M; Meiler, MR; Takano, K; Tatlisumak, T | 1 |
Cole, DJ; Drummond, JC; Ghazal, EA; Shapiro, HM | 1 |
4 other study(ies) available for triphenyltetrazolium and Cerebral Arterial Diseases
Article | Year |
---|---|
Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats.
Topics: Animals; Brain; Calpain; Carotid Artery, Internal; Cell Death; Cerebral Arterial Diseases; Cerebral Infarction; Coloring Agents; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Half-Life; Hypoxia; Image Processing, Computer-Assisted; Ischemic Attack, Transient; Male; Neuroprotective Agents; Neurotoxins; Rats; Rats, Wistar; Tetrazolium Salts; Time Factors | 1998 |
Gender-linked brain injury in experimental stroke.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Autoradiography; Brain; Carbon Radioisotopes; Case-Control Studies; Cerebral Arterial Diseases; Cerebral Cortex; Cerebrovascular Circulation; Cohort Studies; Coloring Agents; Estradiol; Estrogens; Female; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Monitoring, Physiologic; Neuroprotective Agents; Ovariectomy; Putamen; Radiopharmaceuticals; Rats; Rats, Inbred SHR; Rats, Wistar; Reperfusion; Risk Factors; Sex Characteristics; Tetrazolium Salts | 1998 |
A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Topics: Analysis of Variance; Animals; Cerebral Arterial Diseases; Cerebral Cortex; Cerebral Infarction; Coloring Agents; Cortical Spreading Depression; Electroencephalography; Glycine; Infusions, Intravenous; Injections, Intravenous; Ischemic Attack, Transient; Linear Models; Male; N-Methylaspartate; Neuroprotective Agents; Placebos; Pyridazines; Quinolines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Tetrazolium Salts | 1998 |
A reversible component of cerebral injury as identified by the histochemical stain 2,3,5-triphenyltetrazolium chloride (TTC).
Topics: Animals; Arterial Occlusive Diseases; Brain; Cerebral Arterial Diseases; Functional Laterality; Ischemic Attack, Transient; Male; Rats; Rats, Inbred Strains; Staining and Labeling; Tetrazolium Salts | 1990 |